Clinical Trial Update: Nitazoxanide for Treatment of Cryptosporidium in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating nitazoxanide for treating Cryptosporidium infections in children; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Cryptosporidiosis | Phase 3 | Status: NOT_YET_RECRUITING